Climate
Gabon, home to the medicinal plant behind ibogaine, wants a fairer share of its global boom
Publication: Conservation news
Authors: Latoya Abulu, Molly Helfend
Source published: 01/10/2026, 15:21:02 UTC
Briefing created: 01/10/2026, 23:40:48 UTC
Based on a feed excerpt; full article content has not been acquired. Source evidence retrieved 01/10/2026, 23:39:24 UTC.
Briefings
Gabonese officials and practitioners argue that the lucrative global demand for ibogaine is driving overexploitation of the Tabernanthe iboga plant in Gabon's wet forests, creating a financial gap where high international prices exceed local market value. The article describes a market scene in Libreville where sellers sell raw bark powder in repurposed bottles, noting that buyers pay well but treatment costs abroad are prohibitively high. An Interpol analysis from 2023 identified that online reseller trade nearly quadrupled between 2021 and 2023, with the article noting the market may continue to expand despite these concerns.
Key points
- Sellers at the La Peyrie Market in Libreville sell raw iboga bark powder in repurposed bottles, stating buyers pay well despite treatment costs abroad being thousands of dollars per patient.
- An Interpol analysis from 2023 found that online reseller trade of iboga nearly quadrupled between 2021 and 2023, with officials speculating the market may only get bigger.
Context and limitations
The article provides a snapshot of a specific market scene in July 2026 and cites a 2023 Interpol analysis; it does not contain data on total global trade volumes, specific monetary values of illicit trade, or long-term trends beyond the 2021-2023 period.
Generated by Bittrees-hosted qwen35-2b sha256:aaf42c8b7c3c on 01/10/2026, 23:40:48 UTC. Based on publisher-provided feed evidence; may not cover the full original article. Check the source for details.
View archived briefing on IPFS
bafybeidag7s32dck6hgqavccpprgryulmt2gc3hmd3a3c3s4rxipbbjcqe